• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血尿诊断性检查中尿细胞学检查可疑但恶性评估为阴性:如何进行随访?

Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?

作者信息

Nabi G, Greene D, O'Donnell M O

机构信息

Academic Urology Unit, Department of Surgery, University of Aberdeen, Aberdeen AB25 2ZD, UK.

出版信息

J Clin Pathol. 2004 Apr;57(4):365-8. doi: 10.1136/jcp.2003.009696.

DOI:10.1136/jcp.2003.009696
PMID:15047737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1770277/
Abstract

AIMS

To define the natural history of patients with suspicious urinary cytology and negative initial evaluation for malignancy in the investigation of haematuria.

PATIENTS AND METHODS

Data from the hospital information support system on urinary cytology examinations carried out at one centre were audited over a period of 24 months. There were 102 patients who had suspicious urinary cytology for malignant cells with negative initial evaluation. Follow up investigations, treatment, and final outcome were noted.

RESULTS

There were 102 patients with suspicious urinary cytology and negative initial evaluation for malignancy in 24 months, with a mean follow up of 15.7 months. Seventy patients had no obvious pathology on initial investigations. Forty one patients were found to have urological malignancies (29 bladder, eight ureteric, and four prostate) on follow up. All patients diagnosed as having urothelial malignancies on follow up had either persistent suspicious cytology (29) or recurrent haematuria (eight). The mean duration for appearance of lesions was 5.6 months (range, 3-12 months). Three patients had suspicious digital rectal examination and biopsies confirmed adenocarcinoma of the prostate. One patient had urinary retention and transurethral resection of prostate showed prostatic adenocarcinoma. The presence of suspicious cells on repeat urine analysis was the only significant factor in predicting the presence of urothelial tumours (p = 0.002).

CONCLUSION

Patients with persistent suspicious/positive cytology or recurrent haematuria need further evaluation and follow up. Asymptomatic patients or patients with obvious benign pathology do not require repeat evaluation. Careful urological evaluation, including prostate, should be carried out in these patients.

摘要

目的

明确血尿检查中尿细胞学可疑且初始恶性肿瘤评估为阴性的患者的自然病史。

患者与方法

对一家中心在24个月内进行的尿细胞学检查的医院信息支持系统数据进行审核。有102例患者尿细胞学检查发现可疑恶性细胞且初始评估为阴性。记录随访检查、治疗及最终结局。

结果

24个月内有102例患者尿细胞学可疑且初始恶性肿瘤评估为阴性,平均随访15.7个月。70例患者初始检查无明显病理改变。41例患者随访时发现有泌尿系统恶性肿瘤(29例膀胱肿瘤、8例输尿管肿瘤和4例前列腺肿瘤)。所有随访时诊断为尿路上皮恶性肿瘤的患者均有持续性可疑细胞学结果(29例)或复发性血尿(8例)。病变出现的平均时间为5.6个月(范围3 - 12个月)。3例患者直肠指检可疑,活检证实为前列腺腺癌。1例患者出现尿潴留,经尿道前列腺切除术显示为前列腺腺癌。重复尿液分析中存在可疑细胞是预测尿路上皮肿瘤存在的唯一重要因素(p = 0.002)。

结论

持续性可疑/阳性细胞学结果或复发性血尿的患者需要进一步评估和随访。无症状患者或有明显良性病理改变的患者无需重复评估。应对这些患者进行仔细的泌尿系统评估,包括前列腺评估。

相似文献

1
Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?血尿诊断性检查中尿细胞学检查可疑但恶性评估为阴性:如何进行随访?
J Clin Pathol. 2004 Apr;57(4):365-8. doi: 10.1136/jcp.2003.009696.
2
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.使用计算机断层扫描(CT)尿路造影、软性膀胱镜检查和尿液细胞学检查评估膀胱癌的诊断策略:来自医院血尿诊所的 778 例患者的结果。
BJU Int. 2012 Jul;110(1):84-94. doi: 10.1111/j.1464-410X.2011.10664.x. Epub 2011 Nov 28.
3
Is it necessary to perform urine cytology in screening patients with haematuria?对血尿患者进行筛查时,有必要进行尿细胞学检查吗?
Eur Urol. 2001 Mar;39(3):283-6. doi: 10.1159/000052454.
4
Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?膀胱癌患者中可疑的尿液细胞学检查结果(III级):应将其视为阴性还是阳性?
Scand J Urol Nephrol. 2002;36(3):213-7. doi: 10.1080/003655902320131901.
5
Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.排尿尿液及膀胱灌洗细胞学检查在检测尿路移行细胞癌中的诊断价值。
Urol Int. 1999;62(1):26-30. doi: 10.1159/000030350.
6
Grade 2 urethroprostatic papillary urothelial carcinoma with positive urinary cytology.
J Urol. 1985 Jun;133(6):1038-9. doi: 10.1016/s0022-5347(17)49369-4.
7
Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra.卡介苗膀胱内灌注治疗累及前列腺尿道的膀胱浅表性移行细胞癌的长期随访
Clin Genitourin Cancer. 2007 Sep;5(6):386-9. doi: 10.3816/CGC.2007.n.021.
8
Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion.尿细胞学检查在根治性膀胱切除及尿流改道术后监测尿路上皮癌复发中的应用
Cancer Cytopathol. 2016 Apr;124(4):273-8. doi: 10.1002/cncy.21650. Epub 2015 Nov 13.
9
Bladder urothelial neoplasms in pediatric age: experience at three tertiary centers.儿童膀胱尿路上皮肿瘤:三家三级医疗中心的经验
J Pediatr Urol. 2015 Feb;11(1):26.e1-5. doi: 10.1016/j.jpurol.2014.08.008. Epub 2014 Sep 28.
10
Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?评估卡介苗诱导治疗后膀胱原位癌的治疗反应:能否避免诱导治疗后的随机膀胱活检?
Cytopathology. 2014 Apr;25(2):108-11. doi: 10.1111/cyt.12064. Epub 2013 Apr 2.

引用本文的文献

1
Impact of Implementing Paris System on Diagnostic Precision and Management of Urinary Bladder Neoplasms.实施巴黎系统对膀胱肿瘤诊断准确性及管理的影响
Indian J Surg Oncol. 2024 Jun;15(2):225-235. doi: 10.1007/s13193-023-01864-z. Epub 2024 Jan 4.
2
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.针对膀胱癌患者疑似尿液细胞学检查为阴性且经膀胱镜监测为阴性的患者,进行反射荧光原位杂交检测。
BJU Int. 2014 Sep;114(3):354-9. doi: 10.1111/bju.12516. Epub 2014 Feb 14.
3
The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience.膀胱内使用多西他赛治疗卡介苗治疗难治性非肌肉浸润性膀胱癌的新用途:单机构经验。
World J Urol. 2009 Jun;27(3):331-5. doi: 10.1007/s00345-009-0377-1. Epub 2009 Feb 13.

本文引用的文献

1
URINE SEDIMENT SMEARS AS A DIAGNOSTIC PROCEDURE IN CANCERS OF THE URINARY TRACT.尿沉渣涂片作为诊断泌尿道癌症的一种检查方法。
Science. 1945 May 18;101(2629):519-20. doi: 10.1126/science.101.2629.519.
2
How important is urinary cytology in the diagnosis of urological malignancies?
Eur Urol. 2003 Jun;43(6):632-6. doi: 10.1016/s0302-2838(03)00147-7.
3
Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?膀胱癌患者中可疑的尿液细胞学检查结果(III级):应将其视为阴性还是阳性?
Scand J Urol Nephrol. 2002;36(3):213-7. doi: 10.1080/003655902320131901.
4
Is it necessary to perform urine cytology in screening patients with haematuria?对血尿患者进行筛查时,有必要进行尿细胞学检查吗?
Eur Urol. 2001 Mar;39(3):283-6. doi: 10.1159/000052454.
5
Urinary cytologic findings in patients with benign and malignant adenomatous polyps of the prostatic urethra.前列腺尿道良性和恶性腺瘤性息肉患者的尿液细胞学检查结果
Arch Pathol Lab Med. 2000 Jul;124(7):1047-52. doi: 10.5858/2000-124-1047-UCFIPW.
6
Prostatic adenocarcinoma diagnosed by urinary cytology.
Am J Clin Pathol. 2000 Jan;113(1):29-34. doi: 10.1309/4t6h-549r-capj-fey0.
7
Calculus artifact. A challenge in urinary cytology.结石假象。尿液细胞学检查中的一项挑战。
Acta Cytol. 1999 Sep-Oct;43(5):794-800. doi: 10.1159/000331292.
8
Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat.排除标准提高了NMP22和BTA stat的特异性和阳性预测值。
J Urol. 1999 Jul;162(1):53-7. doi: 10.1097/00005392-199907000-00014.
9
Reliability of the routine cytological diagnosis in bladder cancer.膀胱癌常规细胞学诊断的可靠性
Eur Urol. 1999;35(3):228-32. doi: 10.1159/000019851.
10
Rapid detection of bladder cancer: a comparative study of point of care tests.膀胱癌的快速检测:即时检测方法的比较研究
J Urol. 1997 Dec;158(6):2098-101. doi: 10.1016/s0022-5347(01)68166-7.